LSE creators

Number of items: 6.
Centre for Economic Performance
  • Costa-Font, Joan, McGuire, Alistair, Varol, Nebibe (2015). Regulation effects on the adoption of new medicines. Empirical Economics, 49(3), 1101-1121. https://doi.org/10.1007/s00181-014-0903-x
  • Costa-Font, Joan, McGuire, Alistair, Varol, Nebibe (2014). Price regulation and relative delays in generic drug adoption. Journal of Health Economics, 38, 1-9. https://doi.org/10.1016/j.jhealeco.2014.04.004
  • Varol, Nebibe, Costa-Font, Joan, McGuire, Alistair (2012). Does adoption of pharmaceutical innovation respond to changes in the regulatory environment? Applied Economic Perspectives and Policy, 34(3), 531-553. https://doi.org/10.1093/aepp/pps027
    • European Institute
  • Costa-Font, Joan, McGuire, Alistair, Varol, Nebibe (2014). Price regulation and relative delays in generic drug adoption. Journal of Health Economics, 38, 1-9. https://doi.org/10.1016/j.jhealeco.2014.04.004
  • Varol, Nebibe, Costa-Font, Joan, McGuire, Alistair (2012). Does adoption of pharmaceutical innovation respond to changes in the regulatory environment? Applied Economic Perspectives and Policy, 34(3), 531-553. https://doi.org/10.1093/aepp/pps027
  • Costa-i-Font, Joan, Varol, Nebibe, McGuire, Alistair (2011). Does pharmaceutical price regulation affect the adoption of generic competition?: evidence from the OECD, 1999-2008. (CESifo working paper 3441). CESifo Group.
  • Varol, Nebibe, Costa-i-Font, Joan, McGuire, Alistair (2010). Do international launch strategies of pharmaceutical corporations respond to changes in the regulatory environment? (LSE Health working papers 19/2010). LSE Health, London School of Economics and Political Science.
    • Health Policy
  • Costa-Font, Joan, McGuire, Alistair, Varol, Nebibe (2014). Price regulation and relative delays in generic drug adoption. Journal of Health Economics, 38, 1-9. https://doi.org/10.1016/j.jhealeco.2014.04.004
  • Varol, Nebibe, Costa-Font, Joan, McGuire, Alistair (2012). Does adoption of pharmaceutical innovation respond to changes in the regulatory environment? Applied Economic Perspectives and Policy, 34(3), 531-553. https://doi.org/10.1093/aepp/pps027
    • LSE
  • Varol, Nebibe (2010). Regulation and adoption dynamics of pharmaceutical technologies: evidence from the OECD, 1999-2008 [Doctoral thesis]. London School of Economics and Political Science. picture_as_pdf
    • LSE Health
  • Costa-Font, Joan, McGuire, Alistair, Varol, Nebibe (2015). Regulation effects on the adoption of new medicines. Empirical Economics, 49(3), 1101-1121. https://doi.org/10.1007/s00181-014-0903-x
  • Varol, Nebibe, Costa-Font, Joan, McGuire, Alistair (2012). Does adoption of pharmaceutical innovation respond to changes in the regulatory environment? Applied Economic Perspectives and Policy, 34(3), 531-553. https://doi.org/10.1093/aepp/pps027
  • Costa-i-Font, Joan, Varol, Nebibe, McGuire, Alistair (2011). Does pharmaceutical price regulation affect the adoption of generic competition?: evidence from the OECD, 1999-2008. (CESifo working paper 3441). CESifo Group.
  • Varol, Nebibe, Costa-i-Font, Joan, McGuire, Alistair (2010). Do international launch strategies of pharmaceutical corporations respond to changes in the regulatory environment? (LSE Health working papers 19/2010). LSE Health, London School of Economics and Political Science.
    • Social Policy
  • Costa-Font, Joan, McGuire, Alistair, Varol, Nebibe (2015). Regulation effects on the adoption of new medicines. Empirical Economics, 49(3), 1101-1121. https://doi.org/10.1007/s00181-014-0903-x
  • Costa-Font, Joan, McGuire, Alistair, Varol, Nebibe (2014). Price regulation and relative delays in generic drug adoption. Journal of Health Economics, 38, 1-9. https://doi.org/10.1016/j.jhealeco.2014.04.004
  • Varol, Nebibe, Costa-Font, Joan, McGuire, Alistair (2012). Does adoption of pharmaceutical innovation respond to changes in the regulatory environment? Applied Economic Perspectives and Policy, 34(3), 531-553. https://doi.org/10.1093/aepp/pps027
  • Costa-i-Font, Joan, Varol, Nebibe, McGuire, Alistair (2011). Does pharmaceutical price regulation affect the adoption of generic competition?: evidence from the OECD, 1999-2008. (CESifo working paper 3441). CESifo Group.
  • Varol, Nebibe, Costa-i-Font, Joan, McGuire, Alistair (2010). Do international launch strategies of pharmaceutical corporations respond to changes in the regulatory environment? (LSE Health working papers 19/2010). LSE Health, London School of Economics and Political Science.